The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inhibition of gastric cancer by a new controlled releasing compound of TLR-7/8 agonist via immune activation in a gastric cancer xenograft mice model.
 
Hyun Myong Kim
No Relationships to Disclose
 
Kyoungyun Jeong
No Relationships to Disclose
 
Jaeun Yoo
No Relationships to Disclose
 
Yie-Ri Yoo
No Relationships to Disclose
 
Ji-Yeon Shin
No Relationships to Disclose
 
Leena Lim
No Relationships to Disclose
 
Juhee Jeong
No Relationships to Disclose
 
Changhwan Yoon
No Relationships to Disclose
 
Sandra Ryeom
No Relationships to Disclose
 
Sam S. Yoon
Stock and Other Ownership Interests - Attis Lab
 
Do Joong Park
No Relationships to Disclose
 
Hyuk-Joon Lee
Research Funding - JW Pharmaceutical; Olympus
 
Han-Kwang Yang
Consulting or Advisory Role - Stryker
Research Funding - Stryker
 
Do-Youn Oh
Consulting or Advisory Role - Arcus Biosciences; ASLAN Pharmaceuticals; AstraZeneca; Basilea; Bayer; BeiGene; Celgene; Genentech/Roche; Halozyme; IQVIA; Merck Serono; Novartis; Taiho Pharmaceutical; Turning Point Therapeutics; Yuhan; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; BeiGene; Handok; Lilly; MSD; Novartis; SERVIER
 
Keehoon Jung
No Relationships to Disclose
 
Yong Taik Lim
No Relationships to Disclose
 
Seong-Ho Kong
Employment - Vitcal
Leadership - Vitcal
Stock and Other Ownership Interests - MedicalIP; Medifarmsoft
Research Funding - Stryker
Patents, Royalties, Other Intellectual Property - VITCAL co.,ltd.